This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Gerhard Noelken: Innovator in Medicinal Microbiology
Introduction
Gerhard Noelken is a notable inventor based in Sulzbach, Germany. He has made significant contributions to the field of medicinal microbiology, particularly through his innovative work involving the microorganism Ustilago maydis.
Latest Patents
Noelken holds a patent for "Ustilipides, method for the production and the use thereof." This invention pertains to new active agents, known as ustilipides, which are formed by the fermentation of Ustilago maydis, FH 2634, DSM 11494. The patent outlines a method for producing these ustilipides and their application as medicaments in treating schizophrenia and other diseases linked to dopamine metabolic dysfunction. Additionally, the invention includes medicaments containing ustilipides and the microorganism Ustilago maydis.
Career Highlights
Gerhard Noelken is associated with Aventis Pharma Deutschland, GmbH, where he has been instrumental in advancing research and development in pharmaceutical applications. His work has paved the way for new therapeutic options in the treatment of complex neurological disorders.
Collaborations
Noelken has collaborated with esteemed colleagues such as Joachim Wink and László Vértesy, contributing to a rich environment of innovation and research within the pharmaceutical industry.
Conclusion
Gerhard Noelken's contributions to medicinal microbiology and his innovative patent for ustilipides highlight his role as a key figure in the development of new treatments for serious health conditions. His work continues to influence the field and offers hope for improved therapeutic strategies.